Pharmaceutical composition, methods for treating and uses thereof
作者： Rolf Grempler , Odd-Eric Johansen , Thomas Klein , Gerd Luippold , Michael Mark
DOI:
关键词:
摘要: The invention relates to the treatment or prevention of one more conditions selected from type 1 diabetes mellitus, 2 impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition present methods for preventing treating metabolic disorders related conditions.
lens.org参考文章(465)
Matthew C. Riddle, Oral pharmacologic management of type 2 diabetes. American Family Physician. ,vol. 60, pp. 2613- ,(1999)
Louise Profit, Carole Nadin, Paul Chrisp, Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus Core Evidence. ,vol. 3, pp. 13- 30 ,(2008) , 10.3355/CE.2008.009
Ralph A. DeFronzo, Ele Ferrannini, Leif Groop, Robert R. Henry, William H. Herman, Jens Juul Holst, Frank B. Hu, C. Ronald Kahn, Itamar Raz, Gerald I. Shulman, Donald C. Simonson, Marcia A. Testa, Ram Weiss, Type 2 diabetes mellitus. Nature Reviews Disease Primers. ,vol. 1, pp. 15019- ,(2015) , 10.1038/NRDP.2015.19
Yoon-Sik Jun, Ju-Bin Yim, Young Gwan Jo, Ja-Seong Koo, Matrix tablets providing an extended release of metformin ,(2006)
Jerry Meece, When oral agents fail: optimizing insulin therapy in the older adult. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists. pp. 11- ,(2009)
Shashank R Joshi, Metformin: old wine in new bottle--evolving technology and therapy in diabetes. Journal of Association of Physicians of India. ,vol. 53, pp. 963- 972 ,(2005)
Baptist Gallwitz, Saxagliptin, a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. IDrugs : the investigational drugs journal. ,vol. 11, pp. 906- 917 ,(2008)
Paul Habermann, Frank Zocher, Amidated glargine insulin ,(2007)
Shigenobu Mizusaki, Shinzo Noda, Calorie reducing agent ,(2001)